| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |